Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia: Egyptian Experience

BACKGROUND: Acute lymphoblastic leukemia (ALL) is a clonal disease that affects early lymphoid progenitors in the bone marrow. Minimal residual disease (MRD) is assessed by different methods to monitor disease kinetics after treatment. AIM: to Assess MRD post-induction, at 6 and 12 months after inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Rasha Ibrahim, Saeed, Alia Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587864/
https://www.ncbi.nlm.nih.gov/pubmed/35633549
http://dx.doi.org/10.31557/APJCP.2022.23.5.1647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587864/
https://www.ncbi.nlm.nih.gov/pubmed/35633549
http://dx.doi.org/10.31557/APJCP.2022.23.5.1647

Ejemplares similares